SCHEMBL31582533

SCHEMBL31582533

Cc1ccc(C(Br)C(=O)OC(C)(C)C)c2c1c(C)nn2C

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31582650 0.81 SLC16A3 (0.34) LMNAKMT2AKDM4E
SCHEMBL31582899 0.76 — —
SCHEMBL31583019 0.74 — —
SCHEMBL31583004 0.72 MTNR1A (0.36) LMNAKDM4E
SCHEMBL31583219 0.72 LMNA (0.35) LMNAKMT2A
SCHEMBL31582981 0.71 LMNA (0.36) LMNAKDM4E
SCHEMBL25976805 0.71 PDE4A (0.33) LMNAKMT2A
SCHEMBL31582655 0.71 LMNA (0.33) LMNA
SCHEMBL31583107 0.69 SMN1; SMN2 (0.31) KDM4E
SCHEMBL31582842 0.69 KDM4E (0.36) LMNAKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025106644-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ALPHA-V BETA-1 INTEGRIN MORPHIC THERAPEUTIC, INC. (US) 2025-05-22 — — WO disclosed
Send feedback